Skip to main content

Eliminating Uncertainty in Coronary Artery Disease

Project description

Advancing PET measurement of myocardial blood flow

The assessment of myocardial blood flow is carried out by positron emission tomography (PET) using 15O-water, a radioactive variation of regular water as a tracer. However, the short half-life of 15O-water alongside difficulties in image analysis have prohibited its widespread clinical use. Scientists of the EU-funded EU-CAD project are working on a new hardware and analytical software combination to aid clinicians all over the world with 15O-water PET images. The project aims to further develop the current prototype and validate it in patients before obtaining regulatory approval to operate in Europe. Given the implication of myocardial blood flow in coronary heart disease, a robust measurement approach will help patient outcomes.

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Coordinator

MEDTRACE PHARMA A/S
Address
Diplomvej 381
2800 Kongens Lyngby
Denmark

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 500 000